Drugs / MK1809
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01033318 | Sep 2007 → Jun 2008 | hypertensive disorder | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK1809 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01033318 ↗ |
| Route | Oral | “single oral doses of MK1809” NCT01033318 ↗ |